Atchinson Robert

CIK 00014034049 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001403404

Recent Transactions

40 trades

Purchase
ABEONA THERAPEUTICS INC.$ABEO
Pre-funded Warrant (right to buy)
2024-05-07$4.07/sh+2,948,475→ 2,948,475 total
Other
Abacus Global Management, Inc.$ABL
Class A Common Stock, $0.0001 par value
2023-01-23$10.21/sh−2,348,214→ 0 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2017-05-26$77.66/sh−111,823→ 4,451,298 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2017-05-26$78.35/sh−330→ 4,450,968 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2017-05-26$76.72/sh−187,847→ 4,563,121 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2017-05-25$77.61/sh−232,190→ 4,833,252 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2017-05-25$76.91/sh−85,526→ 5,065,442 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2017-05-25$79.70/sh−75,036→ 4,750,968 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2017-05-25$78.25/sh−7,248→ 4,826,004 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2017-05-24$72.22/sh−52,300→ 5,491,653 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2017-05-24$70.31/sh−53,600→ 5,543,953 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock, par value $0.0001 ("Common Stock")
2017-05-24$68.13/sh−50,000→ 5,636,668 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2017-05-24$69.00/sh−39,115→ 5,597,553 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2017-05-24$74.49/sh−48,865→ 5,267,101 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2017-05-24$73.29/sh−175,687→ 5,315,966 total
Sale
PUMA BIOTECHNOLOGY, INC.$PBYI
Common Stock
2017-05-24$75.00/sh−116,133→ 5,150,968 total
Sale
PACIFIC SUNWEAR OF CALIFORNIA INC
Common Stock
2016-04-06$0.11/sh−2,404,880→ 5,127,926 total
Sale
PACIFIC SUNWEAR OF CALIFORNIA INC
Common Stock
2016-04-06$0.13/sh−10,000→ 7,532,806 total
Sale
PACIFIC SUNWEAR OF CALIFORNIA INC
Common Stock
2016-04-05$0.12/sh−500,000→ 7,542,806 total
Sale
PACIFIC SUNWEAR OF CALIFORNIA INC
Common Stock, par value $0.01 ("Common Stock")
2016-04-05$0.09/sh−1,907,247→ 8,042,806 total
Purchase
Calithera Biosciences, Inc.
Common Stock
2015-09-23$6.07/sh+40,168→ 3,135,069 total
Purchase
Calithera Biosciences, Inc.
Common Stock
2015-09-22$6.00/sh+41,800→ 3,094,901 total
Purchase
Calithera Biosciences, Inc.
Common Stock, par value $0.0001 ("Common Stock")
2015-09-22$6.00/sh+25,000→ 3,053,101 total
Purchase
Ayala Pharmaceuticals, Inc.
Common Stock
2015-08-24$14.47/sh+12,100→ 5,939,366 total
Purchase
Ayala Pharmaceuticals, Inc.
Common Stock
2015-08-24$12.90/sh+20,000→ 5,914,366 total
Purchase
Ayala Pharmaceuticals, Inc.
Common Stock
2015-08-24$13.87/sh+5,000→ 5,894,366 total
Purchase
Ayala Pharmaceuticals, Inc.
Common Stock
2015-08-24$13.73/sh+9,500→ 5,927,266 total
Purchase
Ayala Pharmaceuticals, Inc.
Common Stock
2015-08-24$14.06/sh+3,400→ 5,917,766 total
Purchase
Ayala Pharmaceuticals, Inc.
Common Stock
2015-08-21$14.21/sh+75,000→ 5,889,366 total
Purchase
Ayala Pharmaceuticals, Inc.
Common Stock, par value $0.001 ("Common Stock")
2015-08-20$14.28/sh+103,818→ 5,743,184 total
Purchase
Ayala Pharmaceuticals, Inc.
Common Stock
2015-08-20$14.32/sh+45,582→ 5,788,766 total
Purchase
Ayala Pharmaceuticals, Inc.
Common Stock
2015-08-20$14.17/sh+12,000→ 5,814,366 total
Purchase
Ayala Pharmaceuticals, Inc.
Common Stock
2015-08-20$14.31/sh+13,600→ 5,802,366 total
Sale
BOULDER BRANDS, INC.
Common Stock
2012-12-31$13.00/sh−700→ 6,502,078 total
Sale
BOULDER BRANDS, INC.
Common Stock
2012-12-31$12.90/sh−60,902→ 6,502,778 total
Sale
BOULDER BRANDS, INC.
Common Stock, par value $0.0001 per share ("Common Stock")
2012-12-28$12.87/sh−100,000→ 6,619,918 total
Sale
BOULDER BRANDS, INC.
Common Stock
2012-12-28$12.86/sh−56,238→ 6,563,680 total
Conversion
BOULDER BRANDS, INC.
Common Stock, $0.0001 par value ("Common Stock")
2008-01-03+1,409,157→ 5,889,881 total
Conversion
BOULDER BRANDS, INC.
Series A Covertible Preferred Stock ("Preferred Stock")
2008-01-03−1,111,111→ 0 total
Sale
HUBBELL INC$HUBB
Class A Common Stock
2007-11-05$57.04/sh−25,000→ 742,000 total

Companies

Recent Filings

Address

200 CLARENDON STREET 52ND FLOOR

BOSTON, MA, 02116

View on SEC.gov